PetIQ Inc (PETQ)
30.98
0.00 (0.00%)
USD |
NASDAQ |
Oct 25, 16:00
PetIQ Revenue (TTM): 1.134B for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 1.134B |
March 31, 2024 | 1.120B |
December 31, 2023 | 1.102B |
September 30, 2023 | 1.066B |
June 30, 2023 | 998.82M |
March 31, 2023 | 936.29M |
December 31, 2022 | 921.51M |
September 30, 2022 | 934.07M |
June 30, 2022 | 934.88M |
March 31, 2022 | 953.88M |
December 31, 2021 | 932.53M |
September 30, 2021 | 900.10M |
June 30, 2021 | 851.65M |
March 31, 2021 | 847.62M |
December 31, 2020 | 780.05M |
September 30, 2020 | 770.18M |
Date | Value |
---|---|
June 30, 2020 | 794.12M |
March 31, 2020 | 747.77M |
December 31, 2019 | 709.43M |
September 30, 2019 | 666.12M |
June 30, 2019 | 611.48M |
March 31, 2019 | 561.98M |
December 31, 2018 | 528.61M |
September 30, 2018 | 469.52M |
June 30, 2018 | 398.69M |
March 31, 2018 | 314.72M |
December 31, 2017 | 266.69M |
September 30, 2017 | 259.67M |
June 30, 2017 | 240.79M |
March 31, 2017 | 214.89M |
December 31, 2016 | 200.16M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
709.43M
Minimum
Dec 2019
1.134B
Maximum
Jun 2024
917.64M
Average
932.53M
Median
Dec 2021
Revenue (TTM) Benchmarks
Omeros Corp | -- |
BioCardia Inc | 0.428M |
Revance Therapeutics Inc | 243.90M |
Zevra Therapeutics Inc | 23.99M |
Alector Inc | 61.51M |